Nu Skin Enterprises (NYSE:NUS) Posts Earnings Results, Beats Estimates By $0.14 EPS

Nu Skin Enterprises (NYSE:NUS) released its quarterly earnings data on Thursday. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14, Zacks reports. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. Nu Skin Enterprises updated its Q1 2025 guidance to 0.100-0.200 EPS and its FY 2025 guidance to 0.900-1.300 EPS.

Nu Skin Enterprises Stock Performance

NYSE:NUS traded up $0.09 during mid-day trading on Thursday, reaching $6.41. 1,299,428 shares of the stock were exchanged, compared to its average volume of 687,522. The company has a 50 day simple moving average of $6.91 and a 200-day simple moving average of $7.50. The stock has a market capitalization of $318.40 million, a P/E ratio of -3.09 and a beta of 1.17. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises has a 1 year low of $5.95 and a 1 year high of $17.68.

Analyst Ratings Changes

A number of research firms have recently commented on NUS. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Monday, November 11th. Citigroup dropped their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd. Finally, DA Davidson dropped their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.